Form D · Pharmaceuticals
Astrocyte Pharmaceuticals Inc.
Groton, CT · CIK 0001703017
Offering snapshot reported Oct 28, 2022 · SEC filing
- Reported sold
- $2.84M Offering amount: $5M
- Investors reported
- 48 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 13, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 28, 2022 | Initial | $2,840,361 | No comparison | 48 | SEC filing |
| Dec 10, 2020 | Initial | $7,522,677 | No comparison | 70 | SEC filing |
| Jul 28, 2017 | Amendment | $2,415,409 | $1,060,130vs Apr 7, 2017 | 46 | SEC filing |
| Apr 7, 2017 | Initial | $1,355,279 | No comparison | 25 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-463124
Source: Form D, filed Oct 28, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Arnold | Director |
| Christine Gallagher | Director |
| Jeffrey Ives | Director |
| William S. Korinek | Director, Executive |
| James D. Lechleiter | Director |
| Jackson Streeter | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
93 Shennecossett Road
Groton, CT, 06340
Groton, CT, 06340